Does PATISIRAN Cause Product dose omission issue? 175 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 175 reports of Product dose omission issue have been filed in association with PATISIRAN (Onpattro). This represents 6.5% of all adverse event reports for PATISIRAN.
175
Reports of Product dose omission issue with PATISIRAN
6.5%
of all PATISIRAN reports
11
Deaths
113
Hospitalizations
How Dangerous Is Product dose omission issue From PATISIRAN?
Of the 175 reports, 11 (6.3%) resulted in death, 113 (64.6%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PATISIRAN. However, 175 reports have been filed with the FAERS database.
What Other Side Effects Does PATISIRAN Cause?
Death (250)
Fatigue (165)
Infusion related reaction (134)
Hospitalisation (127)
Asthenia (108)
Fall (107)
Intentional dose omission (107)
Cardiac failure (95)
Dyspnoea (87)
Malaise (82)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which PATISIRAN Alternatives Have Lower Product dose omission issue Risk?
PATISIRAN vs PAXIL
PATISIRAN vs PAZOPANIB
PATISIRAN vs PEANUT
PATISIRAN vs PEG INTERFERON
PATISIRAN vs PEG-INTERFERON ALFA 2A